Yuan, Qi
Dridi, Haikel
Clarke, Oliver B.
Reiken, Steven
Melville, Zephan
Wronska, Anetta
Kushnir, Alexander
Zalk, Ran
Sittenfeld, Leah
Marks, Andrew R.
Funding for this research was provided by:
National Institutes of Health (R01HL145473, R01DK118240, R01HL142903, R01HL140934, R01AR070194, T32HL120826, R25 NS076445)
Article History
Received: 26 October 2021
Accepted: 31 October 2021
First Online: 22 November 2021
Declarations
:
: ARM is on the scientific advisory board, board of directors and is an equity owner in ARMGO, Inc. a biotech company targeting RyR for therapeutic purposes, Columbia University also owns equity in ARMGO, Inc.